🎯 check Rosiglitazone (BRL 49653) product page
Rosiglitazone (BRL 49653) is a potent, highly selective PPARγ agonist. It affects PPAR and insulin signaling pathways by binding to the receptor's ligand-binding domain to regulate target gene transcription, effectively promoting adipocyte differentiation and improving systemic insulin sensitivity.